-
Specializing in providing
IR consulting services to
Healthcare & Biotechnology
companies in the US and around the world. -
Specializing in providing
IR consulting services to
Healthcare & Biotechnology
companies in the US and around the world. -
Specializing in providing
IR consulting services to
Healthcare & Biotechnology
companies in the US and around the world. -
Specializing in providing
IR consulting services to
Healthcare & Biotechnology
companies in the US and around the world.
About Us
We represent prominent public, private, and pre-IPO companies in all stages of development and have represented more than two hundred biotechnology, specialty pharmaceuticals, devices, healthcare services and industrial biotechnology over the last 14 years. We are based in New York City.
Investor Relations Services
We offer a broad range of strategic investor relations services that includes working with senior management to achieve key investor relations goals, such as effective positioning, enhancing visibility, improving institutional ownership and sell-side coverage, preparing for financings and IPOs, developing good guidance practices and managing communications around M&A, binary events and other strategic issues.
Our Clients
Our goal is to help each client realize a valuation that best reflects the company's assets and the internal value of the company through favorable interactions with the investment community. We are deeply committed to each client’s success and maintaining a collaborative working relationship.
- Acceleron Pharma
- Acorda Therapeutics
- Agios Pharmaceuticals
- Alkermes
- Alnylam Pharmaceuticals
- BIND Biosciences
- BioSpecifics Technologies
- Cambrex
- Cara
- Chimerix
- Codexis
- Curis
- Endocyte
- Epizyme
- Fate Therapeutics
- ImmunoGen
- Ironwood Pharmaceuticals
- Mesoblast
- Millennium
- Momenta Pharmaceuticals
- NPS Pharmaceuticals
- Proteostasis Therapeutics
- Prothena
- SciClone Pharmaceuticals
- Takeda
- Tengion
- Verenium